212 related articles for article (PubMed ID: 24516603)
1. Obscurins: Goliaths and Davids take over non-muscle tissues.
Ackermann MA; Shriver M; Perry NA; Hu LY; Kontrogianni-Konstantopoulos A
PLoS One; 2014; 9(2):e88162. PubMed ID: 24516603
[TBL] [Abstract][Full Text] [Related]
2. The kinase domains of obscurin interact with intercellular adhesion proteins.
Hu LY; Kontrogianni-Konstantopoulos A
FASEB J; 2013 May; 27(5):2001-12. PubMed ID: 23392350
[TBL] [Abstract][Full Text] [Related]
3. Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.
Bagnato P; Barone V; Giacomello E; Rossi D; Sorrentino V
J Cell Biol; 2003 Jan; 160(2):245-53. PubMed ID: 12527750
[TBL] [Abstract][Full Text] [Related]
4. Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.
Perry NA; Shriver M; Mameza MG; Grabias B; Balzer E; Kontrogianni-Konstantopoulos A
FASEB J; 2012 Jul; 26(7):2764-75. PubMed ID: 22441987
[TBL] [Abstract][Full Text] [Related]
5. Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.
Ackermann MA; King B; Lieberman NAP; Bobbili PJ; Rudloff M; Berndsen CE; Wright NT; Hecker PA; Kontrogianni-Konstantopoulos A
J Mol Cell Cardiol; 2017 Oct; 111():27-39. PubMed ID: 28826662
[TBL] [Abstract][Full Text] [Related]
6. Obscurins: unassuming giants enter the spotlight.
Perry NA; Ackermann MA; Shriver M; Hu LY; Kontrogianni-Konstantopoulos A
IUBMB Life; 2013 Jun; 65(6):479-86. PubMed ID: 23512348
[TBL] [Abstract][Full Text] [Related]
7. Obscurin, a giant sarcomeric Rho guanine nucleotide exchange factor protein involved in sarcomere assembly.
Young P; Ehler E; Gautel M
J Cell Biol; 2001 Jul; 154(1):123-36. PubMed ID: 11448995
[TBL] [Abstract][Full Text] [Related]
8. Molecular interactions with obscurin are involved in the localization of muscle-specific small ankyrin1 isoforms to subcompartments of the sarcoplasmic reticulum.
Armani A; Galli S; Giacomello E; Bagnato P; Barone V; Rossi D; Sorrentino V
Exp Cell Res; 2006 Nov; 312(18):3546-58. PubMed ID: 16962094
[TBL] [Abstract][Full Text] [Related]
9. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle.
Ford-Speelman DL; Roche JA; Bowman AL; Bloch RJ
Mol Biol Cell; 2009 Sep; 20(17):3905-17. PubMed ID: 19605563
[TBL] [Abstract][Full Text] [Related]
10. Obscure functions: the location-function relationship of obscurins.
Manring HR; Carter OA; Ackermann MA
Biophys Rev; 2017 Jun; 9(3):245-258. PubMed ID: 28510116
[TBL] [Abstract][Full Text] [Related]
11. Obscurin interacts with a novel isoform of MyBP-C slow at the periphery of the sarcomeric M-band and regulates thick filament assembly.
Ackermann MA; Hu LY; Bowman AL; Bloch RJ; Kontrogianni-Konstantopoulos A
Mol Biol Cell; 2009 Jun; 20(12):2963-78. PubMed ID: 19403693
[TBL] [Abstract][Full Text] [Related]
12. Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.
Tuntithavornwat S; Shea DJ; Wong BS; Guardia T; Lee SJ; Yankaskas CL; Zheng L; Kontrogianni-Konstantopoulos A; Konstantopoulos K
Cancer Lett; 2022 Feb; 526():155-167. PubMed ID: 34826548
[TBL] [Abstract][Full Text] [Related]
13. Unraveling obscurins in heart disease.
Grogan A; Kontrogianni-Konstantopoulos A
Pflugers Arch; 2019 May; 471(5):735-743. PubMed ID: 30099631
[TBL] [Abstract][Full Text] [Related]
14. Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit.
Shriver M; Marimuthu S; Paul C; Geist J; Seale T; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Oncotarget; 2016 Jul; 7(29):45414-45428. PubMed ID: 27323778
[TBL] [Abstract][Full Text] [Related]
15. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system.
Bang ML; Centner T; Fornoff F; Geach AJ; Gotthardt M; McNabb M; Witt CC; Labeit D; Gregorio CC; Granzier H; Labeit S
Circ Res; 2001 Nov; 89(11):1065-72. PubMed ID: 11717165
[TBL] [Abstract][Full Text] [Related]
16. Obscurin targets ankyrin-B and protein phosphatase 2A to the cardiac M-line.
Cunha SR; Mohler PJ
J Biol Chem; 2008 Nov; 283(46):31968-80. PubMed ID: 18782775
[TBL] [Abstract][Full Text] [Related]
17. Obscurin: A multitasking giant in the fight against cancer.
Guardia T; Eason M; Kontrogianni-Konstantopoulos A
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188567. PubMed ID: 34015411
[TBL] [Abstract][Full Text] [Related]
18. Obscurin regulates the organization of myosin into A bands.
Kontrogianni-Konstantopoulos A; Catino DH; Strong JC; Randall WR; Bloch RJ
Am J Physiol Cell Physiol; 2004 Jul; 287(1):C209-17. PubMed ID: 15013951
[TBL] [Abstract][Full Text] [Related]
19. Obscurin: a multitasking muscle giant.
Kontrogianni-Konstantopoulos A; Bloch RJ
J Muscle Res Cell Motil; 2005; 26(6-8):419-26. PubMed ID: 16625317
[TBL] [Abstract][Full Text] [Related]
20. Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.
Shriver M; Stroka KM; Vitolo MI; Martin S; Huso DL; Konstantopoulos K; Kontrogianni-Konstantopoulos A
Oncogene; 2015 Aug; 34(32):4248-59. PubMed ID: 25381817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
